Total Payments
$1,006
2024 Payments
$29.68
Companies
6
Transactions
20
Medicare Patients
3,547
Medicare Billing
$384,213
Payment Breakdown by Category
Food & Beverage$1,006 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,006 | 20 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $772.06 | 15 | $0 (2023) |
| Novo Nordisk Inc | $121.83 | 1 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $64.86 | 1 | $0 (2023) |
| Alkermes, Inc. | $29.68 | 1 | $0 (2024) |
| Horizon Therapeutics plc | $11.17 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $29.68 | 1 | Alkermes, Inc. ($29.68) |
| 2023 | $178.89 | 3 | Novartis Pharmaceuticals Corporation ($107.91) |
| 2021 | $121.83 | 1 | Novo Nordisk Inc ($121.83) |
| 2019 | $65.22 | 3 | Novartis Pharmaceuticals Corporation ($54.05) |
| 2018 | $354.96 | 7 | Novartis Pharmaceuticals Corporation ($354.96) |
| 2017 | $255.14 | 5 | Novartis Pharmaceuticals Corporation ($255.14) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/24/2024 | Alkermes, Inc. | VIVITROL (Drug) | Food and Beverage | In-kind items and services | $29.68 | General |
| Category: CNS | ||||||
| 11/02/2023 | Sumitomo Pharma America, Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $6.12 | General |
| Category: CNS | ||||||
| 10/05/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $64.86 | General |
| Category: Central Nervous System | ||||||
| 02/12/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $107.91 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/30/2021 | Novo Nordisk Inc | RYBELSUS (Drug) | Food and Beverage | In-kind items and services | $121.83 | General |
| Category: Diabetes | ||||||
| 03/27/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $23.16 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/22/2019 | Horizon Therapeutics plc | RAYOS (Drug), RAYOS, RAYOS | Food and Beverage | In-kind items and services | $11.17 | General |
| Category: RAYOS | ||||||
| 01/10/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $30.89 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/12/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $28.28 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/11/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $49.05 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/09/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $124.90 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/22/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $7.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/29/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), SERELAXIN | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/18/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $124.82 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/02/2018 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $6.03 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/14/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $114.80 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/13/2017 | Novartis Pharmaceuticals Corporation | SERELAXIN (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| 11/12/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $74.95 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/07/2017 | Novartis Pharmaceuticals Corporation | SERELAXIN (Drug) | Food and Beverage | In-kind items and services | $27.48 | General |
| 01/11/2017 | Novartis Pharmaceuticals Corporation | SERELAXIN (Drug) | Food and Beverage | In-kind items and services | $24.66 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 881 | 1,204 | $201,112 | $101,242 |
| 2022 | 18 | 918 | 1,213 | $200,515 | $94,934 |
| 2021 | 16 | 676 | 953 | $143,270 | $71,907 |
| 2020 | 22 | 1,072 | 1,537 | $231,015 | $116,130 |
Total Patients
3,547
Total Services
4,907
Medicare Billing
$384,213
Procedure Codes
75
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 224 | 259 | $72,520 | $36,370 | 50.2% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 143 | 152 | $34,200 | $15,960 | 46.7% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 75 | 120 | $10,800 | $7,285 | 67.5% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 61 | 88 | $13,200 | $6,389 | 48.4% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 36 | 109 | $13,625 | $6,364 | 46.7% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 81 | 110 | $13,200 | $5,942 | 45.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 38 | 51 | $7,140 | $4,657 | 65.2% |
| 99349 | Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes | Office | 2023 | 21 | 38 | $6,650 | $3,806 | 57.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 65 | 78 | $7,020 | $2,758 | 39.3% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 11 | 13 | $2,977 | $2,334 | 78.4% |
| 99347 | Residence visit for established patient with straightforward medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 25 | 65 | $4,875 | $2,142 | 43.9% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 16 | 16 | $3,520 | $1,975 | 56.1% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Facility | 2023 | 40 | 56 | $4,480 | $1,680 | 37.5% |
| G0182 | Physician supervision of a patient under a medicare-approved hospice (patient not present) requiring complex and multidisciplinary care modalities involving regular physician development and/or revision of care plans, review of subsequent reports of patien | Office | 2023 | 18 | 18 | $2,160 | $1,513 | 70.0% |
| 99304 | Initial nursing facility care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 16 | 19 | $2,945 | $1,040 | 35.3% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 11 | 12 | $1,800 | $1,027 | 57.1% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 239 | 263 | $73,640 | $34,277 | 46.5% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 106 | 119 | $26,775 | $12,312 | 46.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 103 | 192 | $17,280 | $10,581 | 61.2% |
| 99335 | Established patient custodial care facility, group care, or assisted living visit, typically 25 minutes | Office | 2022 | 33 | 83 | $13,280 | $5,893 | 44.4% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 74 | 103 | $12,360 | $5,257 | 42.5% |
| 99309 | Follow-up nursing facility visit per day, typically 25 minutes | Facility | 2022 | 44 | 57 | $8,550 | $4,133 | 48.3% |
| 99334 | Established patient custodial care facility, group care, or assisted living visit, typically 15 minutes | Office | 2022 | 33 | 76 | $7,600 | $3,364 | 44.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 33 | 41 | $5,740 | $3,267 | 56.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 77 | 85 | $7,650 | $3,082 | 40.3% |
About Dr. Fadi Salloum, MD
Dr. Fadi Salloum, MD is a Internal Medicine healthcare provider based in Pontiac, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1205874831.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Fadi Salloum, MD has received a total of $1,006 in payments from pharmaceutical and medical device companies, with $29.68 received in 2024. These payments were reported across 20 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($1,006).
As a Medicare-enrolled provider, Salloum has provided services to 3,547 Medicare beneficiaries, totaling 4,907 services with total Medicare billing of $384,213. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Pontiac, MI
- Active Since 06/04/2006
- Last Updated 07/15/2010
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1205874831
Products in Payments
- ENTRESTO (Drug) $706.67
- RYBELSUS (Drug) $121.83
- SERELAXIN (Drug) $65.39
- Austedo XR (Drug) $64.86
- VIVITROL (Drug) $29.68
- RAYOS (Drug) $11.17
- APTIOM (Drug) $6.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Pontiac
Dr. Tina Abraham, D.o, D.O
Internal Medicine — Payments: $703,997
Internal Medicine $703,997
Dipam Shah, Md, MD
Internal Medicine — Payments: $198,148
Internal Medicine $198,148
Dr. Vasimahmed Lala, Do, DO
Internal Medicine — Payments: $45,374
Internal Medicine $45,374
Dr. Matthew Edwards, D.o,, D.O,
Internal Medicine — Payments: $24,196
Internal Medicine $24,196
Rami Arabo, Md, MD
Internal Medicine — Payments: $4,521
Internal Medicine $4,521
Michael Krivitsky, D.o, D.O
Internal Medicine — Payments: $3,445
Internal Medicine $3,445